SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-006315
Filing Date
2020-06-19
Accepted
2020-06-19 15:46:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 18775
2 GRAPHIC g942178g01v16.jpg GRAPHIC 2673
3 GRAPHIC g942178g71p75.jpg GRAPHIC 1420
4 GRAPHIC g942178g71y03.jpg GRAPHIC 8149
5 GRAPHIC g942178g74a18.jpg GRAPHIC 3546
  Complete submission text file 0000950123-20-006315.txt   41998
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations